Wazdan Brings Slots to FanDuel Casino in Pennsylvania
The European slots developer lands in a top-three U.S. iGaming state with 12 Bells and Hot Slot: 777 Crown.

Wazdan has taken its FanDuel Casino partnership into Pennsylvania, adding its slots to one of the U.S.'s most competitive regulated iGaming markets as of June 2026.
Why It Matters
Pennsylvania sits alongside New Jersey and Michigan as a top-three U.S. iGaming revenue state, making any new content deal there commercially significant. FanDuel Casino holds a leading market-share position in regulated online casino, so distribution through its platform gives Wazdan immediate reach to a large, active player base. The initial wave of titles — 12 Bells and Hot Slot: 777 Crown — gives Pennsylvania players their first taste of Wazdan's volatility-focused slot mechanics. For operators and suppliers watching the U.S. market, this deal signals that European slot developers can now convert global product libraries into meaningful American distribution at pace. As always, casino play carries financial risk; players should set strict session limits.
Context
Wazdan and FanDuel Casino had an existing iGaming partnership before this Pennsylvania expansion, per SBC Americas. Wazdan built its reputation on configurable volatility features and high-variance math models that differentiate its titles from commodity slot content. Pennsylvania's iGaming framework, regulated by the Pennsylvania Gaming Control Board, requires individual game certification — meaning each new title clears a meaningful compliance hurdle before going live.
What's Next
Additional Wazdan titles are scheduled to roll out on FanDuel Casino in Pennsylvania beyond the first wave, though no specific release dates have been confirmed. The partnership's trajectory suggests further state-by-state expansion remains on the table as Wazdan pursues broader U.S. certification coverage.
Keep reading
WeeBet Weekly
The week's biggest market move, in 4 minutes.
Every Friday: the top Polymarket/Kalshi price shift, one regulatory story that actually matters, and one chart. No fluff, no promo. Free.
Free. Unsubscribe in one click. We'll never sell your email.